Johnson Matthey PLC (LON:JMAT - Get Free Report) shares rose 32% on Thursday . The company traded as high as GBX 1,888 ($25.62) and last traded at GBX 1,833 ($24.87). Approximately 4,525,127 shares were traded during mid-day trading, an increase of 64% from the average daily volume of 2,755,086 shares. The stock had previously closed at GBX 1,389 ($18.85).
Johnson Matthey Stock Down 1.5%
The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The business's fifty day simple moving average is GBX 1,313.40 and its two-hundred day simple moving average is GBX 1,377.22. The company has a market cap of £2.85 billion, a PE ratio of 28.96, a PEG ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) earnings per share (EPS) for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. On average, analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Johnson Matthey Increases Dividend
The business also recently announced a dividend, which was paid on Wednesday, April 16th. Stockholders of record on Thursday, April 10th were given a GBX 32 ($0.43) dividend. This is a positive change from Johnson Matthey's previous dividend of $22.00. The ex-dividend date was Thursday, April 10th. This represents a dividend yield of 1.88%. Johnson Matthey's dividend payout ratio (DPR) is 130.84%.
Insider Activity
In related news, insider Liam Condon bought 27 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were acquired at an average price of GBX 1,445 ($19.61) per share, for a total transaction of £390.15 ($529.38). Insiders have purchased a total of 75 shares of company stock worth $99,927 over the last 90 days. 0.61% of the stock is currently owned by company insiders.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Featured Articles
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
